Statistics for Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues

Total visits

views
Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues 0

Total visits per month

views
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0

File Visits

views
CJIDMM.2006.876252.pdf 31